163 related articles for article (PubMed ID: 38178222)
1. Assessing the protection elicited by virus-like particles expressing the RSV pre-fusion F and tandem repeated G proteins against RSV rA2 line19F infection in mice.
Kim MJ; Chu KB; Lee SH; Mao J; Eom GD; Yoon KW; Moon EK; Quan FS
Respir Res; 2024 Jan; 25(1):7. PubMed ID: 38178222
[TBL] [Abstract][Full Text] [Related]
2. Additive protection induced by mixed virus-like particles presenting respiratory syncytial virus fusion or attachment glycoproteins.
Lee S; Quan FS; Kwon Y; Sakamoto K; Kang SM; Compans RW; Moore ML
Antiviral Res; 2014 Nov; 111():129-35. PubMed ID: 25239522
[TBL] [Abstract][Full Text] [Related]
3. Virus-Like Particle Vaccine Containing the F Protein of Respiratory Syncytial Virus Confers Protection without Pulmonary Disease by Modulating Specific Subsets of Dendritic Cells and Effector T Cells.
Kim KH; Lee YT; Hwang HS; Kwon YM; Kim MC; Ko EJ; Lee JS; Lee Y; Kang SM
J Virol; 2015 Nov; 89(22):11692-705. PubMed ID: 26355098
[TBL] [Abstract][Full Text] [Related]
4. Alternative Virus-Like Particle-Associated Prefusion F Proteins as Maternal Vaccines for Respiratory Syncytial Virus.
Blanco JCG; Fernando LR; Zhang W; Kamali A; Boukhvalova MS; McGinnes-Cullen L; Morrison TG
J Virol; 2019 Dec; 93(23):. PubMed ID: 31511382
[TBL] [Abstract][Full Text] [Related]
5. A single intranasal administration of virus-like particle vaccine induces an efficient protection for mice against human respiratory syncytial virus.
Jiao YY; Fu YH; Yan YF; Hua Y; Ma Y; Zhang XJ; Song JD; Peng XL; Huang J; Hong T; He JS
Antiviral Res; 2017 Aug; 144():57-69. PubMed ID: 28529001
[TBL] [Abstract][Full Text] [Related]
6. The Respiratory Syncytial Virus (RSV) G Protein Enhances the Immune Responses to the RSV F Protein in an Enveloped Virus-Like Particle Vaccine Candidate.
McGinnes Cullen L; Luo B; Wen Z; Zhang L; Durr E; Morrison TG
J Virol; 2023 Jan; 97(1):e0190022. PubMed ID: 36602367
[TBL] [Abstract][Full Text] [Related]
7. Virus-like particles coexpressing the PreF and Gt antigens of respiratory syncytial virus confer protection in mice.
Chu KB; Lee SH; Kim MJ; Kim AR; Moon EK; Quan FS
Nanomedicine (Lond); 2022 Jul; 17(17):1159-1171. PubMed ID: 36103224
[No Abstract] [Full Text] [Related]
8. Effect of Previous Respiratory Syncytial Virus Infection on Murine Immune Responses to F and G Protein-Containing Virus-Like Particles.
McGinnes Cullen L; Schmidt MR; Morrison TG
J Virol; 2019 May; 93(9):. PubMed ID: 30760576
[TBL] [Abstract][Full Text] [Related]
9. Cotton rat immune responses to virus-like particles containing the pre-fusion form of respiratory syncytial virus fusion protein.
Cullen LM; Blanco JC; Morrison TG
J Transl Med; 2015 Nov; 13():350. PubMed ID: 26541285
[TBL] [Abstract][Full Text] [Related]
10. Virus-like particle vaccines containing F or F and G proteins confer protection against respiratory syncytial virus without pulmonary inflammation in cotton rats.
Hwang HS; Kim KH; Lee Y; Lee YT; Ko EJ; Park S; Lee JS; Lee BC; Kwon YM; Moore ML; Kang SM
Hum Vaccin Immunother; 2017 May; 13(5):1031-1039. PubMed ID: 28129031
[TBL] [Abstract][Full Text] [Related]
11. Prophylaxis with a respiratory syncytial virus (RSV) anti-G protein monoclonal antibody shifts the adaptive immune response to RSV rA2-line19F infection from Th2 to Th1 in BALB/c mice.
Boyoglu-Barnum S; Chirkova T; Todd SO; Barnum TR; Gaston KA; Jorquera P; Haynes LM; Tripp RA; Moore ML; Anderson LJ
J Virol; 2014 Sep; 88(18):10569-83. PubMed ID: 24990999
[TBL] [Abstract][Full Text] [Related]
12. Chimeric virus-like particles containing a conserved region of the G protein in combination with a single peptide of the M2 protein confer protection against respiratory syncytial virus infection.
Qiao L; Zhang Y; Chai F; Tan Y; Huo C; Pan Z
Antiviral Res; 2016 Jul; 131():131-40. PubMed ID: 27154395
[TBL] [Abstract][Full Text] [Related]
13. Modification of the respiratory syncytial virus f protein in virus-like particles impacts generation of B cell memory.
Schmidt MR; McGinnes-Cullen LW; Kenward SA; Willems KN; Woodland RT; Morrison TG
J Virol; 2014 Sep; 88(17):10165-76. PubMed ID: 24965456
[TBL] [Abstract][Full Text] [Related]
14. Novel Respiratory Syncytial Virus-Like Particle Vaccine Composed of the Postfusion and Prefusion Conformations of the F Glycoprotein.
Cimica V; Boigard H; Bhatia B; Fallon JT; Alimova A; Gottlieb P; Galarza JM
Clin Vaccine Immunol; 2016 Jun; 23(6):451-9. PubMed ID: 27030590
[TBL] [Abstract][Full Text] [Related]
15. A Single-Dose Recombinant Parainfluenza Virus 5-Vectored Vaccine Expressing Respiratory Syncytial Virus (RSV) F or G Protein Protected Cotton Rats and African Green Monkeys from RSV Challenge.
Wang D; Phan S; DiStefano DJ; Citron MP; Callahan CL; Indrawati L; Dubey SA; Heidecker GJ; Govindarajan D; Liang X; He B; Espeseth AS
J Virol; 2017 Jun; 91(11):. PubMed ID: 28298602
[TBL] [Abstract][Full Text] [Related]
16. Co-immunization with virus-like particle and DNA vaccines induces protection against respiratory syncytial virus infection and bronchiolitis.
Hwang HS; Kwon YM; Lee JS; Yoo SE; Lee YN; Ko EJ; Kim MC; Cho MK; Lee YT; Jung YJ; Lee JY; Li JD; Kang SM
Antiviral Res; 2014 Oct; 110():115-23. PubMed ID: 25110201
[TBL] [Abstract][Full Text] [Related]
17. Intranasal Vaccination with a Respiratory-Syncytial-Virus-Based Virus-like Particle Displaying the G Protein Conserved Region Induces Severe Weight Loss and Pathology upon Challenge with Wildtype Respiratory Syncytial Virus.
Terhüja M; Siddappa M; Lamichhane P; Meshram CD; Snider TA; Ritchey JW; Oomens AGP
Viruses; 2024 May; 16(6):. PubMed ID: 38932136
[TBL] [Abstract][Full Text] [Related]
18. Protection induced by virus-like particle vaccine containing tandem repeat gene of respiratory syncytial virus G protein.
Kim AR; Lee DH; Lee SH; Rubino I; Choi HJ; Quan FS
PLoS One; 2018; 13(1):e0191277. PubMed ID: 29338045
[TBL] [Abstract][Full Text] [Related]
19. Protective antigenic sites identified in respiratory syncytial virus fusion protein reveals importance of p27 domain.
Lee J; Lee Y; Klenow L; Coyle EM; Tang J; Ravichandran S; Golding H; Khurana S
EMBO Mol Med; 2022 Jan; 14(1):e13847. PubMed ID: 34750984
[TBL] [Abstract][Full Text] [Related]
20. Virus-Like Particles Assembled Using Respiratory Syncytial Virus Matrix Protein Elicit Protective Immunity in Mice.
Lee SH; Chu KB; Kim MJ; Quan FS
Infect Drug Resist; 2023; 16():6099-6110. PubMed ID: 37719656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
